Table 3. The treatment and outcome of COVID-19 infection in children.
Clinical data (Case no.) | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
---|---|---|---|---|---|---|---|
Clinical typing | Mild | Mild | Mild | Mild | Moderate | Asymptomatic | Mild |
Ending | RD | RD | RD | RD | RD | RD e | RD |
Duration of positive nucleic acid test (two consecutive intervals of 24 hours) (days) | 26 | 11 | 15 | 14 | 13 | 6 | 14 |
Length of stay (days) | 31 | 12 | 16 | 15 | 12 | 8 | 17 |
Treatment | |||||||
Interferon atomization | Y | Y | Y | Y | Y | Y | Y |
Lianhua Qingwen | Y | Y | Y | Y | Y | Y | |
Inosine | Y | ||||||
Reduced glutathione | Y | ||||||
Abidol | Y | Y | Y | Y | Y | ||
Oseltamivir | Y | Y | Y | ||||
Azithromycin | Y | Y | Y | Y | |||
TCM | Y | Y | Y | Y | |||
Leucogen | Y |
COVID-19, coronavirus disease 2019; RD, recovery and discharge; TCM, Traditional Chinese medicine; Y, yes.